Immunosuppressive regimens after liver transplantation Surgery Immunosuppressive regimens after liver transplantation
Conditions
Interventions
In this observational study, compliance and quality of life are monitored in patients whose basic immunosuppressive regimen is changed to a once daily formulation using standardised questionnaires
Sponsors
University Hospital Heidelberg (Germany)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. More than or equal to 12 months after liver transplantation 2. Aged more than or equal to 18 years 3. Change in immunosuppressive regimen to a retard formulation
Exclusion criteria
Exclusion criteria: 1. Intellectual or language barriers in understanding and answering the questionnaires 2. Patients admitted to the hospital
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life as measured with the SF-36 health questionnaire | — |
Secondary
| Measure | Time frame |
|---|---|
| Compliance as measured with the BAASIS interview | — |
Countries
Germany
Outcome results
None listed